KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Labcorp Holdings (LH) Cost of Revenue (2016 - 2025)

Labcorp Holdings' Cost of Revenue history spans 17 years, with the latest figure at $2.5 billion for Q4 2025.

  • For Q4 2025, Cost of Revenue rose 3.68% year-over-year to $2.5 billion; the TTM value through Dec 2025 reached $9.9 billion, up 5.91%, while the annual FY2025 figure was $9.9 billion, 5.91% up from the prior year.
  • Cost of Revenue for Q4 2025 was $2.5 billion at Labcorp Holdings, down from $2.5 billion in the prior quarter.
  • Across five years, Cost of Revenue topped out at $2.7 billion in Q3 2021 and bottomed at $328.2 million in Q4 2021.
  • The 5-year median for Cost of Revenue is $2.4 billion (2024), against an average of $2.2 billion.
  • The largest annual shift saw Cost of Revenue plummeted 87.3% in 2021 before it surged 549.48% in 2022.
  • A 5-year view of Cost of Revenue shows it stood at $328.2 million in 2021, then soared by 549.48% to $2.1 billion in 2022, then increased by 3.77% to $2.2 billion in 2023, then increased by 10.0% to $2.4 billion in 2024, then increased by 3.68% to $2.5 billion in 2025.
  • Per Business Quant, the three most recent readings for LH's Cost of Revenue are $2.5 billion (Q4 2025), $2.5 billion (Q3 2025), and $2.5 billion (Q2 2025).